The real question is whether the overall plan supports fat loss with muscle preservation , not just weight loss alone
2 NEJM Semaglutide and Weight Loss (STEP trials)Randomized controlled trial of once-weekly semaglutide for weight management and its metabolic effects
Clinical trial data from the NEJM Phase 2 study showed that gastrointestinal events were predominantly mild to moderate, occurred primarily during dose escalation, and were partially mitigated by starting at 2mg rather than 4mg
Other side effects listed on WebMD include: Uneven skin tone Facial redness or flushing Headaches Reduced appetite Painful, prolonged erections, which can permanently damage the penis Melanoma (skin cancer)
Glow BPC 157 10mg + GHK-CU 50mg + TB500 10mg Dosing & Observed Effects in Research In preclinical animal models, BPC 157 has been studied at doses ranging from 6 to 50 g/kg body weight using intraperitoneal, intramuscular, or oral routes
Coverage limits remain